The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 26, 2021
Filed:
Dec. 20, 2017
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Gail Lewis Phillips, South San Francisco, CA (US);
Deepak Sampath, South San Francisco, CA (US);
Ingrid Wertz, South San Francisco, CA (US);
Assignee:
Genentech, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/32 (2006.01); G01N 33/574 (2006.01); A61K 47/68 (2017.01); A61K 31/635 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 31/496 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 31/496 (2013.01); A61K 31/635 (2013.01); A61K 45/06 (2013.01); A61K 47/6803 (2017.08); A61K 47/6809 (2017.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 16/32 (2013.01); G01N 33/57415 (2013.01); G01N 33/57446 (2013.01); A61K 2039/505 (2013.01); A61K 2300/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); G01N 2333/4703 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer.